{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:01:40Z","timestamp":1779962500842,"version":"3.53.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00535-026-02380-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:53:25Z","timestamp":1776668005000},"page":"765-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel driver gene FIRRM regulates the cell cycle for promoting tumor growth in hepatocellular carcinoma"],"prefix":"10.1007","volume":"61","author":[{"given":"Tomohiko","family":"Ikehara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Otsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Tobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ofuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Shibuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koto","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Itoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Omachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3897-9974","authenticated-orcid":false,"given":"Koshi","family":"Mimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"2380_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2380_CR2","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","volume":"149","author":"J Zucman-Rossi","year":"2015","unstructured":"Zucman-Rossi J, Villanueva A, Nault JC, et al. Genetic landscape and biomarkers of hepatocellular carcinoma. Gastroenterology. 2015;149:1226-39.e4.","journal-title":"Gastroenterology"},{"key":"2380_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10:35.","journal-title":"Signal Transduct Target Ther"},{"key":"2380_CR4","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.cell.2013.10.011","volume":"155","author":"T Davoli","year":"2013","unstructured":"Davoli T, Xu AW, Mengwasser KE, et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell. 2013;155:948\u201362.","journal-title":"Cell"},{"key":"2380_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bjc.6602448","volume":"92","author":"P Moinzadeh","year":"2005","unstructured":"Moinzadeh P, Breuhahn K, St\u00fctzer H, et al. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade\u2013results of an explorative CGH meta-analysis. Br J Cancer. 2005;92:935\u201341.","journal-title":"Br J Cancer"},{"key":"2380_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1005778","volume":"12","author":"R Uchi","year":"2016","unstructured":"Uchi R, Takahashi Y, Niida A, et al. Integrated multiregional analysis proposing a new model of colorectal cancer evolution. PLoS Genet. 2016;12:e1005778.","journal-title":"PLoS Genet"},{"key":"2380_CR7","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5701","author":"Y Nakano","year":"2024","unstructured":"Nakano Y, Masuda T, Sakamoto T, et al. SHARPIN is a novel gene of colorectal cancer that promotes tumor growth potentially via inhibition of p53 expression. Int J Oncol. 2024. https:\/\/doi.org\/10.3892\/ijo.2024.5701.","journal-title":"Int J Oncol"},{"key":"2380_CR8","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/cas.16129","volume":"115","author":"M Hashimoto","year":"2024","unstructured":"Hashimoto M, Masuda T, Nakano Y, et al. Tumor suppressive role of the epigenetic master regulator BRD3 in colorectal cancer. Cancer Sci. 2024;115:1866\u201380.","journal-title":"Cancer Sci"},{"key":"2380_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/cas.15174","volume":"113","author":"K Koike","year":"2022","unstructured":"Koike K, Masuda T, Sato K, et al. GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Cancer Sci. 2022;113:156\u201369.","journal-title":"Cancer Sci"},{"key":"2380_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol. 2022;32:30\u201344.","journal-title":"Trends Cell Biol"},{"key":"2380_CR11","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","volume":"35","author":"M Ingham","year":"2017","unstructured":"Ingham M, Schwartz GK. Cell-cycle therapeutics come of age. J Clin Oncol. 2017;35:2949\u201359.","journal-title":"J Clin Oncol"},{"key":"2380_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrd4504","volume":"14","author":"U Asghar","year":"2015","unstructured":"Asghar U, Witkiewicz AK, Turner NC, et al. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015;14:130\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"2380_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jhep.2019.08.017","volume":"72","author":"S Rebouissou","year":"2020","unstructured":"Rebouissou S, Nault JC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol. 2020;72:215\u201329.","journal-title":"J Hepatol"},{"key":"2380_CR14","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.170532","author":"PY Wong","year":"2024","unstructured":"Wong PY, Chan CYK, Xue HDG, et al. Cell cycle inhibitors activate the hypoxia-induced DDX41\/STING pathway to mediate antitumor immune response in liver cancer. JCI Insight. 2024. https:\/\/doi.org\/10.1172\/jci.insight.170532.","journal-title":"JCI Insight"},{"key":"2380_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00608","volume":"8","author":"F Schettini","year":"2018","unstructured":"Schettini F, De Santo I, Rea CG, et al. CDK 4\/6 inhibitors as single agent in advanced solid tumors. Front Oncol. 2018;8:608.","journal-title":"Front Oncol"},{"key":"2380_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117598","volume":"180","author":"J Li","year":"2024","unstructured":"Li J, Cheng X, Huang D, et al. The regulatory role of mitotic catastrophe in hepatocellular carcinoma drug resistance mechanisms and its therapeutic potential. Biomed Pharmacother. 2024;180:117598.","journal-title":"Biomed Pharmacother"},{"key":"2380_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/hepr.13892","volume":"53","author":"K Hasegawa","year":"2023","unstructured":"Hasegawa K, Takemura N, Yamashita T, et al. Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines). Hepatol Res. 2023;53:383\u201390.","journal-title":"Hepatol Res"},{"key":"2380_CR18","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1111\/cas.14163","volume":"110","author":"Y Kouyama","year":"2019","unstructured":"Kouyama Y, Masuda T, Fujii A, et al. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer. Cancer Sci. 2019;110:3132\u201344.","journal-title":"Cancer Sci"},{"key":"2380_CR19","first-page":"5693","volume":"9","author":"TA Masuda","year":"2003","unstructured":"Masuda TA, Inoue H, Nishida K, et al. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Clin Cancer Res. 2003;9:5693\u20138.","journal-title":"Clin Cancer Res"},{"issue":"Suppl 3","key":"2380_CR20","doi-asserted-by":"publisher","first-page":"S1490","DOI":"10.1245\/s10434-015-4652-7","volume":"22","author":"M Ueda","year":"2015","unstructured":"Ueda M, Iguchi T, Nambara S, et al. Overexpression of Transcription Termination Factor 1 is associated with a poor prognosis in patients with colorectal cancer. Ann Surg Oncol. 2015;22(Suppl 3):S1490\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2380_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7150\/ijbs.14242","volume":"12","author":"T Masuda","year":"2016","unstructured":"Masuda T, Xu X, Dimitriadis EK, et al. \u201cDNA Binding Region\u201d of BRCA1 affects genetic stability through modulating the Intra-S-Phase Checkpoint. Int J Biol Sci. 2016;12:133\u201343.","journal-title":"Int J Biol Sci"},{"key":"2380_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000445952","volume":"91","author":"H Otsu","year":"2016","unstructured":"Otsu H, Iimori M, Ando K, et al. Gastric cancer patients with high PLK1 expression and DNA aneuploidy correlate with poor prognosis. Oncology. 2016;91:31\u201340.","journal-title":"Oncology"},{"key":"2380_CR23","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1038\/s41379-021-00825-7","volume":"34","author":"IA Cree","year":"2021","unstructured":"Cree IA, Tan PH, Travis WD, et al. Counting mitoses: SI(ze) matters! Mod Pathol. 2021;34:1651\u20137.","journal-title":"Mod Pathol"},{"key":"2380_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2380_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1053\/j.gastro.2020.03.013","volume":"159","author":"F Wang","year":"2020","unstructured":"Wang F, Hou W, Chitsike L, et al. ABL1, overexpressed in hepatocellular carcinomas, regulates expression of NOTCH1 and promotes development of liver tumors in mice. Gastroenterology. 2020;159:289-305.e16.","journal-title":"Gastroenterology"},{"key":"2380_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13073-021-00981-0","volume":"13","author":"Y Guo","year":"2021","unstructured":"Guo Y, Wang J, Benedict B, et al. Targeting CDC7 potentiates ATR-CHK1 signaling inhibition through induction of DNA replication stress in liver cancer. Genome Med. 2021;13:166.","journal-title":"Genome Med"},{"key":"2380_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112697","volume":"206","author":"Z Deng","year":"2020","unstructured":"Deng Z, Chen G, Liu S, et al. Discovery of methyl 3-((2-((1-(dimethylglycyl)-5-methoxyindolin-6-yl)amino)-5-(trifluoro-methyl) pyrimidin-4-yl)amino)thiophene-2-carboxylate as a potent and selective polo-like kinase 1 (PLK1) inhibitor for combating hepatocellular carcinoma. Eur J Med Chem. 2020;206:112697.","journal-title":"Eur J Med Chem"},{"key":"2380_CR28","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1136\/gutjnl-2016-312268","volume":"66","author":"J Bollard","year":"2017","unstructured":"Bollard J, Miguela V, Ruiz de Galarreta M, et al. Palbociclib (PD-0332991), a selective CDK4\/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut. 2017;66:1286\u201396.","journal-title":"Gut."},{"key":"2380_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.gendis.2019.06.001","volume":"6","author":"W Wang","year":"2019","unstructured":"Wang W, Hu B, Qin JJ, et al. A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance. Genes Dis. 2019;6:419\u201330.","journal-title":"Genes Dis"},{"key":"2380_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109343","volume":"36","author":"L Xu","year":"2021","unstructured":"Xu L, Ali M, Duan W, et al. Feedback control of PLK1 by Apolo1 ensures accurate chromosome segregation. Cell Rep. 2021;36:109343.","journal-title":"Cell Rep"},{"key":"2380_CR31","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nrm3819","volume":"15","author":"S Zitouni","year":"2014","unstructured":"Zitouni S, Nabais C, Jana SC, et al. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014;15:433\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2380_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/embr.201338080","volume":"15","author":"L Zhou","year":"2014","unstructured":"Zhou L, Tian X, Zhu C, et al. Polo-like kinase-1 triggers histone phosphorylation by Haspin in mitosis. EMBO Rep. 2014;15:273\u201381.","journal-title":"EMBO Rep"},{"key":"2380_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106372","volume":"26","author":"J Wang","year":"2023","unstructured":"Wang J, Tian X, Feng C, et al. Histone H3 phospho-regulation by KimH3 in both interphase and mitosis. iScience. 2023;26:106372.","journal-title":"iScience"},{"key":"2380_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf4409","volume":"9","author":"A Mazouzi","year":"2023","unstructured":"Mazouzi A, Moser SC, Abascal F, et al. FIRRM\/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks. Sci Adv. 2023;9:eadf4409.","journal-title":"Sci Adv"},{"key":"2380_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339\u201346.","journal-title":"Nat Genet"},{"key":"2380_CR36","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/386761a0","volume":"386","author":"KW Kinzler","year":"1997","unstructured":"Kinzler KW, Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature. 1997;386:761\u20133.","journal-title":"Nature"},{"key":"2380_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112668","volume":"42","author":"C Stok","year":"2023","unstructured":"Stok C, Tsaridou S, van den Tempel N, et al. FIRRM\/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics. Cell Rep. 2023;42:112668.","journal-title":"Cell Rep"},{"key":"2380_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.tig.2024.02.007","volume":"40","author":"S Tsaridou","year":"2024","unstructured":"Tsaridou S, van Vugt M. FIRRM and FIGNL1: partners in the regulation of homologous recombination. Trends Genet. 2024;40:467\u201370.","journal-title":"Trends Genet"},{"key":"2380_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.693651","volume":"8","author":"J Chen","year":"2021","unstructured":"Chen J, Mai H, Chen H, et al. Pan-cancer analysis identified C1ORF112 as a potential biomarker for multiple tumor types. Front Mol Biosci. 2021;8:693651.","journal-title":"Front Mol Biosci"},{"key":"2380_CR40","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1007\/s00018-021-03789-8","volume":"78","author":"J Edogbanya","year":"2021","unstructured":"Edogbanya J, Tejada-Martinez D, Jones NJ, et al. Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer. Cell Mol Life Sci. 2021;78:4365\u201376.","journal-title":"Cell Mol Life Sci"},{"key":"2380_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41419-024-06727-1","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhao Z, Wang X, et al. Deprivation of methionine inhibits osteosarcoma growth and metastasis via C1orf112-mediated regulation of mitochondrial functions. Cell Death Dis. 2024;15:349.","journal-title":"Cell Death Dis"},{"key":"2380_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.710944","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Tan Z, Lv Q, et al. High expression of C1ORF112 predicts a poor outcome: a potential target for the treatment of low-grade gliomas. Front Genet. 2021;12:710944.","journal-title":"Front Genet"},{"key":"2380_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112907","volume":"42","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Yang H, Liang X, et al. C1orf112 teams up with FIGNL1 to facilitate RAD51 filament disassembly and DNA interstrand cross-link repair. Cell Rep. 2023;42:112907.","journal-title":"Cell Rep"},{"key":"2380_CR44","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-024-45139-9","volume":"15","author":"JD Tischler","year":"2024","unstructured":"Tischler JD, Tsuchida H, Bosire R, et al. FLIP(C1orf112)-FIGNL1 complex regulates RAD51 chromatin association to promote viability after replication stress. Nat Commun. 2024;15:866.","journal-title":"Nat Commun"},{"key":"2380_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1474337","volume":"15","author":"J Qian","year":"2024","unstructured":"Qian J, Liao G, Chen M, et al. Advancing cancer therapy: new frontiers in targeting DNA damage response. Front Pharmacol. 2024;15:1474337.","journal-title":"Front Pharmacol"},{"key":"2380_CR46","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/1078-0432.CCR-22-3335","volume":"29","author":"AJ Compadre","year":"2023","unstructured":"Compadre AJ, van Biljon LN, Valentine MC, et al. RAD51 foci as a biomarker predictive of platinum chemotherapy response in ovarian cancer. Clin Cancer Res. 2023;29:2466\u201379.","journal-title":"Clin Cancer Res"},{"key":"2380_CR47","volume":"1874","author":"Y Wang","year":"2020","unstructured":"Wang Y, Chen H, Zhang J, et al. Mcm family in gastrointestinal cancer and other malignancies: from functional characterization to clinical implication. Biochimica et Biophysica Acta (BBA). 2020;1874:188415.","journal-title":"Biochimica et Biophysica Acta (BBA)"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02380-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02380-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:02:42Z","timestamp":1779958962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02380-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02380-x","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that there are no conflicts of interest associated with this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}